Eli Lilly News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

06.08.13	Positive Opinions, Solid Margins, Agreements, and Clinical Trials to Boost Run Rate of Drug Manufacturers - Research Report on Johnson & Johnson, Pfizer, Merck, Bristol-Myers Squibb, and Lilly (PR Newswire)
01.08.13	Lilly, Roswell Park Cancer Institute Partner to Train Minority Clinical Trial Investigators (PR Newswire)
01.08.13	M&As, Strong Earnings, and Share Repurchase Programs Support Optimism for Healthcare - Research Report on Perrigo, Intuitive Surgical, Biogen Idec, Celgene, and Lilly (PR Newswire)
24.07.13	Pre-market Movers For July 24 (AAPL, BA, LLY, DELL, F, PEP, MFB, VMW, CAT, BRCM) (RTTNews)
24.07.13	Lilly Q2 Profit Rises, Above Estimates; Lifts Forecast (RTTNews)
24.07.13	Lilly Q2 Profit Climbs; Ups 2013 Earnings View - Quick Facts (RTTNews)
24.07.13	Lilly Reports Second-Quarter 2013 Results (PR Newswire)
24.07.13	Earnings Watch For July 24 (BA, CAT, F, FB, V, CA) (RTTNews)
23.07.13	Transition In-licenses TT-601 From Lilly For Osteoarthritis Pain - Quick Facts (RTTNews)
22.07.13	Successful Integrations, Growth Brands, and Pipeline Innovations Boost Revenue Growth - Research Report on Johnson & Johnson, Abbott, St. Jude Medical, Lilly, and Novartis (PR Newswire)
08.07.13	Eli Lilly, Boehringer Say MAA For LY2963016 Accepted For Review By EMA (RTTNews)
08.07.13	Lilly, Boehringer Report Regulatory Submission For Insulin Glargine Biosimilar (RTTNews)
08.07.13	Eli Lilly CEO Returns To Work After Surgery - Update (RTTNews)
08.07.13	Lilly Chairman John Lechleiter Back To Duty After Dilated Aorta Surgery (RTTNews)
08.07.13	Lilly: CMS Issues Draft Decision Proposing Coverage With Evidence Development (RTTNews)
08.06.09	Wall Street Schluss: Später Aufwind, Finanztitel legen zu (Aktiencheck)
06.11.08	Cabernet Pharmaceuticals and Lilly Form Pharmacogenetics Alliance to Help Deliver Tailored Therapeutics to Patients (Businesswire)
11.06.08	NOXXON Pharma AG schliesst Kooperationsvertrag mit Eli Lilly and Company über die Entwicklung von Spiegelmeren(R) zur Migränebehandlung (Businesswire)
21.05.08	Lilly Announces Changes in Key Leadership Roles (PR Newswire)
09.05.08	Seven Summits Research Releases Comments on XOM, NVDA, ICE, LLY, and ATVI (PR Newswire)
30.04.08	Lilly CEO Praises Massachusetts' Leadership in Biotech, Urges Policy Prescriptions to Help Ensure State's Investment Generates Dividends and Jobs (PR Newswire)
11.04.08	ALIMTA(R) (pemetrexed for injection) Receives European Approval for Histologically-Based Use in First-Line Treatment of Most Common Lung Cancer (PR Newswire)
05.03.08	AOL, Lilly and VeriSign Return as Sponsors & NSA Returns as Patron of 2008 TopCoder Open (PR Newswire)
15.11.07	Eli Lilly and Company to Receive Honor from National Urban League (PR Newswire)
06.11.07	Lilly Contributes $10.8 Million to United Way Annual Campaign (PR Newswire)
01.10.07	Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize (PR Newswire)
21.09.07	One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function (PR Newswire)
21.09.07	One Year of Exenatide Treatment Improves Beta-Cell Function (PR Newswire)
19.09.07	EASD/EFSD, Chinese Diabetes Society and Eli Lilly and Company partner to support collaborative diabetes research between China and Europe (PR Newswire)
18.09.07	European Study Outlines Struggle to Control Diabetes, Significant Economic Implications to Healthcare Systems (PR Newswire)
11.07.07	European Commission Approves FORSTEO(R) (teriparatide [rDNA origin] injection) for the Treatment of Osteoporosis in Men (PR Newswire)
02.06.07	Clinical Data Suggest Potential Versatility of ALIMTA(R) (Pemetrexed for Injection)-Based Regimens in Lung Cancer (PR Newswire)
19.02.07	Eli Lilly and Company Aligns with Veterinary Channel Partners (PR Newswire)
19.02.07	Eli Lilly and Company Aligns with Veterinary Channel Partners (Businesswire)
12.02.07	Scholarship Recognizes Adults With Attention-Deficit/Hyperactivity Disorder Striving for Academic Excellence (PR Newswire)
18.01.07	Lilly ICOS LLC Reports Results for 2006 (PR Newswire)
12.01.07	Glass Lewis and PROXY Governance Recommend ICOS Shareholders Vote for Lilly's $34 Per Share Cash Merger (Businesswire)
11.01.07	Lilly Announces Strategic Changes to its Global Manufacturing Operations (PR Newswire)
05.01.07	Lilly and OSI Pharmaceuticals Announce Licensing Agreement (PR Newswire)
17.12.06	Eli Lilly and Company Responds to New York Times Article of 12/17/06 (PR Newswire)
21.11.06	BYETTA(R) (exenatide) Approved for Treatment of Type 2 Diabetes by European Commission (PR Newswire)
28.09.06	2006 Lilly Oncology On Canvas(SM) International Art Competition Receives More Than 2,000 Entries (PR Newswire)
21.07.06	Lilly Reports Second-Quarter EPS of $.76 (PR Newswire)
17.07.06	FDA Approves Lilly's Gemzar(R) For Ovarian Cancer Treatment (PR Newswire)
22.06.06	Sexual Revolutionaries Mature: Baby Boomers Seek Relationship Satisfaction (PR Newswire)
10.06.06	BYETTA(R) Shown to Reduce Blood Glucose Levels When Added to Patients Using a TZD (PR Newswire)
10.06.06	Study Demonstrated Once-Weekly Exenatide LAR Improved Glucose Control in Patients with Type 2 Diabetes (PR Newswire)
10.05.06	Lilly to Extend Patient Assistance Programs for Medicare Patients (PR Newswire)
06.04.06	New Data Show Cialis(R) (tadalafil) is Effective in Treating Erectile Dysfunction Caused by Traumatic Spinal Cord Injury (PR Newswire)
29.03.06	Call for Journalists to Enter the Embrace Award for Accurate, Responsible and Sensitive Reporting of Urinary Incontinence (PR Newswire)
14.03.06	Study Shows More Potent and More Reliable Platelet Inhibition with Prasugrel Compared to Clopidogrel Even in Patients With More Reactive Platelets (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	71.14	1.54 %	K V
UBS Group	28.08	1.48 %	K V
Swiss Re	130.05	1.05 %	K V
Part Grp Hldg	1’266.00	0.96 %	K V
ABB	49.48	0.94 %	K V
Geberit	525.20	0.27 %	K V
Alcon	78.04	0.05 %	K V
Givaudan	3’868.00	-0.31 %	K V
CieFinRichemont	121.20	-0.57 %	K V
Sonova Hldg	301.00	-0.99 %	K V

mehr

28.11.24		TELL me! - der Schweizer Trading Podcast: Microsoft unter Kartellverdacht - Novartis auf einem guten Weg - bei Brenntag könnte das zyklische Tief 2025 kommen
28.11.24		Optimismus in Europa: Euro STOXX 50 zum Ende des Donnerstagshandels in der Gewinnzone
28.11.24		Freundlicher Handel in Frankfurt: LUS-DAX verbucht schlussendlich Gewinne
28.11.24		DAX aktuell: DAX zum Handelsende mit Zuschlägen
28.11.24		Börse Europa: STOXX 50-Börsianer greifen zu
28.11.24		Gewinne in Europa: STOXX 50 am Mittag mit Kursplus
28.11.24		Freundlicher Handel in Europa: Euro STOXX 50 zum Start fester
28.11.24		Börse Frankfurt in Grün: DAX beginnt Handel im Plus

28.11.24

TELL me! - der Schweizer Trading Podcast: Microsoft unter Kartellverdacht - Novartis auf einem guten Weg - bei Brenntag könnte das zyklische Tief 2025 kommen

28.11.24

Optimismus in Europa: Euro STOXX 50 zum Ende des Donnerstagshandels in der Gewinnzone

28.11.24

Freundlicher Handel in Frankfurt: LUS-DAX verbucht schlussendlich Gewinne

28.11.24

DAX aktuell: DAX zum Handelsende mit Zuschlägen

28.11.24

Börse Europa: STOXX 50-Börsianer greifen zu

28.11.24

Gewinne in Europa: STOXX 50 am Mittag mit Kursplus